BioSpace News Archive

SPRINT MIND 2.0 Will Clarify the Role of Intensive Blood Pressure Lowering in Reducing Dementia Risk

Industry-Leading Hemp Manufacturer Announces Research & Development Innovation with Hemp Genetics at 0.0% THC

Wellness Corporate Solutions (WCS), the award-winning national provider of employee wellness programs, welcomes Dawn Irby as an additional Vice President of Sales to their team this month.

Dr. Kirsch shares innovation, expertise with pediatric urologists across the world

Older adults go to the emergency department more often than other age groups, stay longer, and typically require more resources and medical interventions.

Peli BioThermal, the global name in temperature controlled packaging, is exhibiting its award-winning shipper solutions and services at Arab Health for the first time as the company increases its infrastructure and operations in the Middle East.

With the severe dearth of FDA-approved drugs in the reliable treatment of frontotemporal disorders, frontotemporal disorders treatment continues to underscore the growing significance of disease management

This weekend, El Centro Hispano in Jonesboro and Arkansas State University are partnering with the National Alliance for Hispanic Health to host the National Institutes of Health’s All of Us Journey, a traveling, hands-on exhibit that raises awareness about the All of Us Research Program

Physicians’ Education Resource® (PER®), a leading resource for continuing medical education (CME), will host its 23rd annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma from Thursday, Feb. 28 to Sunday, March 3 at the Eden Roc Miami Beach in Florida.

I-Mab Biopharma (“I-Mab”), a China-based clinical stage biopharmaceutical company exclusively focused on the development of innovative biologics in immuno-oncology and autoimmune diseases, announces on Jan. 25, 2019 that its IND application for TJC4, has been approved by the US Food & Drug Administration (FDA).